Author: Hosni, Ali; Chiu, Kevin; Hui Huang, Shao; Xu, Wei; Huang, Jingyue; Bayley, Andrew; Bratman, Scott V.; Cho, John; Giuliani, Meredith; Kim, John; O'Sullivan, Brian; Ringash, Jolie; Waldron, John; Spreafico, Anna; de Almeida, John R.; Monteiro, Eric; Witterick, Ian; Chepeha, Douglas B.; Gilbert, R.W.; Irish, Jonathan C.; Goldstein, David P.; Hope, Andrew
Title: Non-operative management for oral cavity carcinoma: definitive radiation therapy as a potential alternative treatment approach Cord-id: vqjc0f9k Document date: 2020_8_28
ID: vqjc0f9k
Snippet: PURPOSE: To determine the outcomes of oral cavity squamous cell cancer (OSCC) patients treated with non-surgical approach i.e. definitive intensity-modulated radiation therapy (IMRT). METHODS: All OSCC patients treated radically with IMRT (without primary surgery) between 2005-2014 were reviewed in a prospectively collected database. OSCC patients treated with definitive RT received concurrent chemotherapy except for early stage patients or those who declined or were unfit for chemotherapy. The
Document: PURPOSE: To determine the outcomes of oral cavity squamous cell cancer (OSCC) patients treated with non-surgical approach i.e. definitive intensity-modulated radiation therapy (IMRT). METHODS: All OSCC patients treated radically with IMRT (without primary surgery) between 2005-2014 were reviewed in a prospectively collected database. OSCC patients treated with definitive RT received concurrent chemotherapy except for early stage patients or those who declined or were unfit for chemotherapy. The 5-year local, and regional, distant control rates, disease-free, overall, and cancer-specific survival, and late toxicity were analyzed. RESULTS: Among 1316 OSCC patients treated with curative-intent; 108 patients (8%) received non-operative management due to: medical inoperability (n=14, 13%), surgical unresectability (n=8, 7%), patient declined surgery (n=15, 14%), attempted preservation of oral structure/function in view of required extensive surgery (n=53, 49%) or extensive oropharyngeal involvement (n=18, 17%). Sixty-eight (63%) were cT3-4, 38 (35%) were cN2-3, and 38 (35%) received concurrent chemotherapy. With a median follow-up of 52months, the 5-year local, regional, distant control rate, disease-free, overall, and cancer-specific survival were 78%, 92%, 90%, 42%, 50%, and 76% respectively. Patients with cN2-3 had higher rate of 5-year distant metastasis (24% vs 3%, p=0.001), with detrimental impact on DFS (p=0.03) and OS (p<0.02) on multivariable analysis. Grade ≥3 late toxicity was reported in 9% of patients (most common: grade 3 osteoradionecrosis in 6%). CONCLUSIONS: Non-operative management of OSCC resulted in a meaningful rate of locoregional control, and could be an alternative curative approach when primary surgery would be declined, unsuitable or unacceptably delayed.
Search related documents:
Co phrase search for related documents- local control and locoregional control: 1, 2, 3, 4, 5
- local control and locoregional control improve: 1
- local control and lymph node: 1, 2, 3
- local failure and locoregional failure: 1
- local morbidity and lymph node: 1
- locoregional control and lymph node: 1
Co phrase search for related documents, hyperlinks ordered by date